搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Salmonella typhimurium UDP-N-acetylglucosamine 1-carboxyvinyltransferase (murA) CSB-YP353332SXB
CSB-EP353332SXB
CSB-BP353332SXB
CSB-MP353332SXB
CSB-EP353332SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1 (murA1) CSB-YP353333SMT
CSB-EP353333SMT
CSB-BP353333SMT
CSB-MP353333SMT
CSB-EP353333SMT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant UDP-N-acetylenolpyruvoylglucosamine reductase (murB) CSB-YP353334MVH
CSB-EP353334MVH
CSB-BP353334MVH
CSB-MP353334MVH
CSB-EP353334MVH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant UDP-N-acetylenolpyruvoylglucosamine reductase (murB) CSB-YP353335SMH
CSB-EP353335SMH
CSB-BP353335SMH
CSB-MP353335SMH
CSB-EP353335SMH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae UDP-N-acetylenolpyruvoylglucosamine reductase (murB) CSB-YP353336SMP
CSB-EP353336SMP
CSB-BP353336SMP
CSB-MP353336SMP
CSB-EP353336SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant UDP-N-acetylmuramate--L-alanine ligase (murC) CSB-YP353337MVZ
CSB-EP353337MVZ
CSB-BP353337MVZ
CSB-MP353337MVZ
CSB-EP353337MVZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--L-lysine ligase (murE) CSB-YP353338SKX
CSB-EP353338SKX
CSB-BP353338SKX
CSB-MP353338SKX
CSB-EP353338SKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase CSB-YP353339SKY
CSB-EP353339SKY
CSB-BP353339SKY
CSB-MP353339SKY
CSB-EP353339SKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable methylmalonyl-CoA mutase small subunit (mutA), partial CSB-YP353340MVZ
CSB-EP353340MVZ
CSB-BP353340MVZ
CSB-MP353340MVZ
CSB-EP353340MVZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable methylmalonyl-CoA mutase large subunit (mutB), partial CSB-YP353341MVH
CSB-EP353341MVH
CSB-BP353341MVH
CSB-MP353341MVH
CSB-EP353341MVH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus DNA mismatch repair protein mutL (mutL), partial CSB-YP353342SKY
CSB-EP353342SKY
CSB-BP353342SKY
CSB-MP353342SKY
CSB-EP353342SKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Quinolinate synthase A (nadA) CSB-YP353343MVZ
CSB-EP353343MVZ
CSB-BP353343MVZ
CSB-MP353343MVZ
CSB-EP353343MVZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Probable nicotinate-nucleotide adenylyltransferase (nadD) CSB-YP353344SKY
CSB-EP353344SKY
CSB-BP353344SKY
CSB-MP353344SKY
CSB-EP353344SKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable nicotinate-nucleotide adenylyltransferase (nadD) CSB-YP353345FMW
CSB-EP353345FMW
CSB-BP353345FMW
CSB-MP353345FMW
CSB-EP353345FMW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus NH (3)-dependent NAD (+) synthetase CSB-YP353346SUL
CSB-EP353346SUL
CSB-BP353346SUL
CSB-MP353346SUL
CSB-EP353346SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Glutathione-regulated potassium-efflux system ancillary protein KefG (kefG) CSB-YP353347SWW
CSB-EP353347SWW
CSB-BP353347SWW
CSB-MP353347SWW
CSB-EP353347SWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Glucosamine-6-phosphate deaminase (nagB) CSB-YP353348SMH
CSB-EP353348SMH
CSB-BP353348SMH
CSB-MP353348SMH
CSB-EP353348SMH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Putative N-acetylmannosamine-6-phosphate 2-epimerase (nanE) CSB-YP353349SMU
CSB-EP353349SMU
CSB-BP353349SMU
CSB-MP353349SMU
CSB-EP353349SMU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uncharacterized Na (+)/H (+) exchanger Rv2287/MT2345, partial CSB-YP353350MVZ
CSB-EP353350MVZ
CSB-BP353350MVZ
CSB-MP353350MVZ
CSB-EP353350MVZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable ferredoxin/ferredoxin--NADP reductase (fprB), partial CSB-YP353351MVH
CSB-EP353351MVH
CSB-BP353351MVH
CSB-MP353351MVH
CSB-EP353351MVH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>